- FDA Principal Deputy Commissioner Dr. Sara Brenner revealed she avoided COVID-19 vaccination during pregnancy due to concerns about unknown biodistribution (how the vaccine spreads in the body) and potential excretion in breast milk.
- Studies in 2022 and 2023 confirmed mRNA from Pfizer and Moderna vaccines can be detected in breast milk, supporting Brenner's caution.
- The CDC is reportedly ending routine COVID-19 vaccine recommendations for youth and pregnant women amid growing scrutiny of mandates and suppressed dissent within federal health agencies.
- Brenner criticized the lack of transparency during the pandemic, noting officials often presented unverified claims as facts. She described the era as a "dark time" but expressed hope under new leadership, including HHS Secretary Robert F. Kennedy Jr.
- Brenner stressed the need for honesty about medical uncertainties to restore public confidence, as over 80 percent of Americans received at least one COVID-19 shot despite unresolved safety questions.
A high-ranking official of the Food and Drug Administration (FDA) official has revealed that she never received a Wuhan coronavirus (COVID-19) vaccine due to concerns about how the shots distribute in the body – particularly their potential effects on pregnancy and breastfeeding.
FDA Principal Deputy Commissioner Dr. Sara Brenner made this striking admission Thursday, May 15, during an event in Washington, D.C. organized by the newly formed MAHA Institute. The group, named after Health Secretary Robert F. Kennedy Jr.'s Make America Healthy Again agenda, advocates for health policy reform.
Brenner, a preventive medicine specialist with expertise in nanotechnology, explained that she was pregnant during the pandemic. At the time, she hesitated to take the vaccines because the manner of how they spread through the body was not yet fully understood.
"It was unknown at the time what the biodistribution patterns of those products were, and in my case, in particular, what the excretion would be in breast milk," she said. "That was my primary concern."
Subsequent research appears to validate Brenner's caution. A 2022 study detected mRNA from Pfizer and Moderna vaccines in breast milk, and another paper published the following year reinforced those findings.
COVID-19 policies failed public trust
The timing of Brenner's comments is notable, as a health official confirmed to the Epoch Times that the Centers for Disease Control and Prevention (CDC) will no longer advise routine COVID-19 vaccinations for youth and pregnant women. This reversal from its previous stance follows growing scrutiny over vaccine mandates and the sidelining of dissenting voices within federal health agencies. (Related: CDC's dangerous gamble: Pregnant women and their unborn babies at put at unreasonable RISK from SIX toxic vaccines.)
Incumbent FDA Commissioner Dr. Marty Makary has publicly criticized COVID-19 booster recommendations, though he received the initial vaccine series. Brenner served as acting FDA commissioner pending Makary's confirmation by the Senate.
Her remarks also highlight a broader tension within the FDA and the CDC, where some officials have privately questioned the rapid push for mass vaccination without long-term safety data. They ultimately underscore the lack of transparency that plagued pandemic policy.
"One of the biggest misses … was that there was no acknowledgement of what was unknown," said Brenner. "There were only statements and assertions that were really more like beliefs or things that were desired to be true than they were true knowns."
Brenner, who served in both the Trump and Biden administrations, described the past few years as a "dark time." However, she expressed optimism under new leadership – including Kennedy at the Department of Health and Human Services, who has championed vaccine safety reforms.
As the FDA navigates these changes, Brenner emphasized that rebuilding public trust requires honesty about uncertainties in medicine. With over 80 percent of Americans having received at least one COVID-19 shot, her candid remarks may prompt deeper questions about how pandemic policies were shaped – and who was allowed to ask them.
Watch Del Bigtree discussing FDA Commissioner Dr. Marty Makary's demands for real vaccine trials in this clip.
This video is from The HighWire with Del Bigtree channel on Brighteon.com.
More related stories:
FDA names scrutiny advocate Dr. Vinay Prasad to lead vaccine division amid calls for transparency.
FDA reconsiders COVID-19 booster approvals, with Makary emphasizing the need for "good data."
FDA advisory panel to review COVID-19 vaccine strategy.
Sources include:
Please contact us for more information.